Evidence map›Paper›PMID 37888185›Full record

ArticleJournal of functional biomaterials2023

Ingmar Aeneas Jan van Hengel, Bruce van Dijk, Khashayar Modaresifar, Johan Frederik Felix Hooning van Duyvenbode, Faisal Ruben Hamzah Aziz Nurmohamed, Marius Alexander Leeflang, Adriaan Camille Fluit, Lidy Elena Fratila-Apachitei, Iulian Apachitei, Harrie Weinans and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Orthopedic meta-implants.APL bioengineering · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ingmar Aeneas Jan van HengelDepartment of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology, Mekelweg 2, 2628 CD Delft, The Netherlands.ORCID 0000-0002-7171-257X
Bruce van DijkDepartment of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Khashayar ModaresifarDepartment of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology, Mekelweg 2, 2628 CD Delft, The Netherlands.ORCID 0000-0002-0391-8541
Johan Frederik Felix Hooning van DuyvenbodeDepartment of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Faisal Ruben Hamzah Aziz NurmohamedDepartment of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Marius Alexander LeeflangDepartment of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology, Mekelweg 2, 2628 CD Delft, The Netherlands.
Adriaan Camille FluitDepartment of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Lidy Elena Fratila-ApachiteiDepartment of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology, Mekelweg 2, 2628 CD Delft, The Netherlands.ORCID 0000-0002-7341-4445
Iulian ApachiteiDepartment of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology, Mekelweg 2, 2628 CD Delft, The Netherlands.ORCID 0000-0003-4268-1070
Harrie WeinansDepartment of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology, Mekelweg 2, 2628 CD Delft, The Netherlands.
Amir Abbas ZadpoorDepartment of Biomechanical Engineering, Faculty of Mechanical, Maritime, and Materials Engineering, Delft University of Technology, Mekelweg 2, 2628 CD Delft, The Netherlands.
Delft University of Technology · NLUniversity Medical Center Utrecht · NL

Funding

Interreg VA Flanders - The Netherlands 2014TC16RFCB046
6 · The paper itself

Abstract

Additively manufactured (AM) porous titanium implants may have an increased risk of implant-associated infection (IAI) due to their huge internal surfaces. However, the same surface, when biofunctionalized, can be used to prevent IAI. Here, we used a rat implant infection model to evaluate the biocompatibility and infection prevention performance of AM porous titanium against bioluminescent methicillin-resistant

Indexed as

additive manufacturingbone infection modelimplant-associated infectionMRSAsurface biofunctionalizationtitanium bone implants

Identifiers

PMID37888185
PMCPMC10607138
OpenAlexW4387667721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.